Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children

BMJ Open(2020)10.1136/bmjopen-2019-034308Source: DataRank Database

Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children is a research paper published in BMJ Open (2020). On theSindex it has a DataRank of 0.426. It has been cited 10 times, with 3 citing works in its 1-hop citation network.

N/A

0.426DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access10 citations · 3 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02613169

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.17)OA: goldTopics (64)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 85%Citation Network 15%

Base Score Contribution

0.360

From this paper's citation signal

Citation Network Contribution

0.0658

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 3 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 3 citers.

QuantiFERON-TB Gold Plus Performance in Children: A Narrative Review
The Pediatric Infectious Disease Journal202314 citations43 referencesContributes 0.063
Novel strategies based on natural products and synthetic derivatives to overcome resistance in Mycobacterium tuberculosis
European Journal of Medicinal Chemistry20249 citations159 referencesContributes 0.014
Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets
Open Medicine20240 citations29 referencesContributes 0.000

Authors (10)

Barbra A. Richardson ORCID,John Kinuthia ORCID,Alex J. Warr ORCID,Elizabeth Maleche‐Obimbo ORCID,Daniel Matemo ORCID

Live enrichment

PubMed:31969368 PMC:PMC7045242 OpenAlex:https://openalex.org/W3001206296

Fogarty International Center

Grant: R25 TW009345

National Center for Advancing Translational Sciences

Grant: UL1TR000423

National Institute of Allergy and Infectious Diseases

Grant: K23 AI 120793

National Institute of Allergy and Infectious Diseases

Grant: K24 AI 137310

FIC NIH HHS

Grant: D43 TW009345

NIAID NIH HHS

Grant: T32 AI007140

National Institutes of Health

Grant: 5K24AI137310-02

Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection

National Institutes of Health

Grant: 5K23AI120793-04

Impact of maternal HIV on Mycobacterium tuberculosis infection among peripartum women and their infants

National Institutes of Health

Grant: 3UL1TR000423-07S1

Institute of Translational Health Sciences

National Institutes of Health

Grant: 1D43TW013039-01

Building an India-Africa Network to Support Research and Control of Urban Malaria Transmission

National Institutes of Health

Grant: 5R25TW009345-02

Northern/Pacific Universities Global Health Research Training Consortium

Thrasher Research Fund

FWCI

0.17

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

2024

goldLicense: cc-by-nc

journalhttps://bmjopen.bmj.com/content/bmjopen/10/1/e034308.full.pdf

publisherhttps://bmjopen.bmj.com/content/bmjopen/10/1/e034308.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/bmjopen-2019-034308

journalhttps://doi.org/10.1136/bmjopen-2019-034308

repositoryhttps://pubmed.ncbi.nlm.nih.gov/31969368

Fields of Study

Tuberculosis Research and EpidemiologyDiagnosis and treatment of tuberculosisInfectious Diseases and Tuberculosis03 medical and health sciences0302 clinical medicineAntitubercular AgentsFemaleHIVHIV InfectionsHumansIncidenceInfantIsoniazidKenyaMaleMass ScreeningMycobacterium tuberculosisTuberculosisRandomized Controlled Trials as Topic

MeSH Terms

Antitubercular AgentsFemaleHIVHumansInfantIsoniazidKenyaMaleMass ScreeningMycobacterium tuberculosisTuberculosisHIV InfectionsIncidenceRandomized Controlled Trials as Topic

Keywords

MedicineTuberculosisTuberculinIsoniazidPopulationAdverse effectMycobacterium tuberculosisQuantiFERONInternal medicinePediatricsImmunologyDiseaseLatent tuberculosisEnvironmental healthPathologyPreventionProtocolPediatricMaleIncidenceRAntitubercular AgentsHIVInfantHIV InfectionsKenyaInfectious DiseasesHumansMass ScreeningFemaleRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being